Our findings extended a previous report that miR-370 inhibits the progression of NSCLC by targeting the TRAF4 [30], but disagreed with a previous report that miR-370 expression is associated with poor prognosis of lung cancers [29]. The gene discussed is TRAF4; the disease is lung cancer.